Ajinomoto Maintains Overweight Rating; ABF and CDMO Drive Mid-to-Short-Term High Growth
AI summary card
Ajinomoto Maintains Overweight Rating; ABF and CDMO Drive Mid-to-Short-Term High Growth
Despite rising costs, Ajinomoto expects high mid-to-short-term profit growth and maintains its Overweight rating.
- Ajinomoto maintains Overweight rating
- High mid-to-short-term profit growth expected
- ABF and CDMO as primary growth drivers
- Rising costs but impact manageable
- FY2030 operating profit estimate raised to ¥403.7 billion
Report interpretation
Overview
J.P. Morgan maintains its Overweight rating for Ajinomoto, expecting sustained high mid-to-short-term profit growth driven by ABF and CDMO businesses despite rising cost pressures.
Core views
Ajinomoto's unique business portfolio, including ABF and CDMO, is expected to support its short-to-medium-term profit growth trend. Although cost inflation due to worsening Middle East conditions may squeeze profit margins in the food business, J.P. Morgan anticipates client capital expenditure expansion will boost mid-term ABF sales growth. Consequently, J.P. Morgan has raised its FY2030 operating profit estimate to ¥403.7 billion and expects a 17% CAGR in operating profits for FY2027-30, with the healthcare and others segment (primarily ABF and CDMO) increasing its share of operating profits from 30% to 53%.
Analysis framework
Based on expectations of client capital expenditure expansion, J.P. Morgan has raised its ABF sales growth estimates while lowering profit estimates for seasonings & foods and frozen food businesses to reflect cost inflation impacts. J.P. Morgan also updated its valuation base year from FY2026 to FY2027 to account for the anticipated food business earnings recovery and raised its mid-term growth forecast. Thus, J.P. Morgan applied a 37x fair P/E ratio to its FY2027 EPS estimate and set a new FY2026 year-end target price of ¥6,500.
Methodology notes
Free Cash Flow Analysis
Evaluates the company's financial health and growth potential by analyzing its free cash flow.
Supply-Demand Framework
Predicts future profit trends by analyzing supply-demand dynamics within the industry.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Ajinomoto (2802.T)Beneficiary
- Strengths
- Unique business portfolio including ABF and CDMO
- Weaknesses
- Cost inflation due to worsening Middle East conditions
- Comparison
- Compared to industry peers, Ajinomoto demonstrates higher capital efficiency
- Risks
- Cost inflation may impact food business profits
Key data
- FY2030 Operating Profit Estimate¥403.7 billionRaised
- FY2027-30 Operating Profit CAGR17%Raised
- FY2026 Year-End Target Price¥6,500Raised
Impact & implications
J.P. Morgan believes Ajinomoto's unique business portfolio and expected client capital expenditure expansion will support its short-to-medium-term profit growth. Although cost inflation may temporarily impact food business profits, J.P. Morgan expects these effects to be absorbed through sales growth and price adjustments. Additionally, CDMO business growth potential will serve as a key mid-term driver.
Risks
- Cost inflation may lead to declining food business profits
- Intensified overseas competition may slow sales growth
- Inventory adjustments may impact profitability
- Input prices may rise further
What to watch
- Impact of Middle East developments on costs
- Client capital expenditure expansion trends
- ABF and CDMO business growth